Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The clomipramine-lithium combination: controlled trial]

J Nick, J P Luaute, A Des Lauriers

    L'Encephale
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Leflunomide: A safe and effective alternative in systemic lupus erythematosus.

    Autoimmunity reviews·2021
    Same author

    Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review.

    Clinical rheumatology·2020
    Same author

    Influence of the IL17A locus in giant cell arteritis susceptibility.

    Annals of the rheumatic diseases·2014
    Same author

    Recognition memory in psychotic patients.

    Behavioural neurology·2014
    Same author

    Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

    Annals of the rheumatic diseases·2013
    Same author

    [Effect of chondroitin sulfate and hyaluronic acid (500-730 kDa) on synthesis of stromelysin (MMP-3) and MMP-1 in human chondrocyte cultures].

    Reumatologia clinica·2011
    Same journal

    Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

    L'Encephale·2026
    Same journal

    [Empowerment in addictology].

    L'Encephale·2026
    Same journal

    Evaluation of the links between smoking and conspiracy mentality.

    L'Encephale·2026
    Same journal

    Use of a relevance assessment tool in therapeutic residential care: A real world study.

    L'Encephale·2026
    Same journal

    Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

    L'Encephale·2026
    Same journal

    From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

    L'Encephale·2026
    See all related articles

    This study found that combining Clomipramine with Lithium Carbonate did not improve antidepressant efficacy compared to Clomipramine with placebo in patients with recurrent depression. Lithium did not enhance or reduce Clomipramine's effects.

    Area of Science:

    • Psychiatry
    • Clinical Pharmacology

    Background:

    • Recurrent depression is a significant clinical challenge.
    • Pharmacological interventions aim to improve treatment outcomes.

    Purpose of the Study:

    • To evaluate the efficacy of Clomipramine plus Lithium Carbonate versus Clomipramine plus placebo for recurrent depression.
    • To determine if Lithium potentiates or antagonizes Clomipramine's antidepressant effect.

    Main Methods:

    • A controlled, double-blind study with random sampling.
    • 30 patients with recurrent depression participated.
    • An independent observer used a rating scale for results, analyzed statistically.

    Main Results:

    • No significant difference in global antidepressant efficacy was observed between the Clomipramine plus Lithium Carbonate group and the Clomipramine plus placebo group.

    Related Experiment Videos

  • Lithium Carbonate did not appear to potentiate or antagonize the antidepressant effect of Clomipramine.
  • Conclusions:

    • The addition of Lithium Carbonate to Clomipramine does not offer superior antidepressant efficacy for recurrent depression compared to Clomipramine alone.
    • Further research is needed to explore potential subgroup effects, as the current study lacked sufficient power to analyze bipolar versus unipolar depression outcomes.